Immunologic response
VIRUS
The CPT-FPV group demonstrated a significant increase in nucleocapsid IgG antibody levels between days 0–2 (Anti-RBD spike IgG and surrogated virus neutralizing test change after sotrovimab versus combined COVID-19 convalescent plasma with favipiravir treatment.